Central and peripheral autonomic integrity in Parkinson's disease

Age and Ageing

Volumn 37, Issue 5, 2008, Pages 578-581

  Adhiyaman, V ^a   Hobson, P ^a   Meara, R J ^a  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; NORADRENALIN; ROPINIROLE;

AGED; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE MEASUREMENT; BODY POSITION; CONTROLLED STUDY; DISEASE SEVERITY; HEART RATE; HUMAN; LETTER; MAJOR CLINICAL STUDY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE;

AGED; ARGININE VASOPRESSIN; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; HAND STRENGTH; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; MIDDLE AGED; NEURAL PATHWAYS; NOREPINEPHRINE; PARKINSON DISEASE; POSTURE; VALSALVA MANEUVER;

EID: 51749112019     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn149     Document Type: Letter

References (16)

1. Kaufmann H, Oribe E, Miller M et al. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 1992; 42: 590-3.
2. Polinsky RJ. Neuropharmacological investigation of autonomic failure. In: Mathias CJ, Bannister R, eds. Autonomic Failure, A Textbook of Clinical Disorders of the Autonomic Nervous System, 4th edition. Oxford: Oxford University Press, 1999; 232-44.
3. Poole CJM, Williams TDM, Lightman SL et al. Neuroendocrine control of vasopressin secretion and its effect on blood pressure in subjects with spinal cord transection. Brain 1987; 110: 727-35.
4. Niimi Y, Ieda T, Hirayama M et al. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res 1999; 9: 139-44.
5. Langston JW, Forno LS. The hypothalamus in Parkinson's disease. Ann Neurol 1978; 3: 129-33.
6. Wakabayashi K, Takahashi H. Neuropathology of Autonomic Nervous system in Parkinson's disease. Eur Neurol 1997a; 38(Suppl. 2): 2-7.
7. Berrios GE, Campbell C, Politynska BE. Autonomic Failure, depression and anxiety in Parkinson's disease. Br J Psychiatry 1995; 166: 789-92.
8. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple-system atrophy. J Neurol Sci 1996; 144: 218-9.
9. Benarroch EE. Central neurotransmitters and neuromodulators in cardiovascular regulation. In: Mathias CJ, Bannister R, eds. Autonomic Failure, A Textbook of Clinical Disorders of the Autonomic Nervous System, 4th edition. Oxford: Oxford University Press, 1999; 37-44.
10. Goldstein DS. Cardiac denervation in patients with Parkinson disease. Cleve Clin J Med 2007; 74(suppl. 1): S91-4.
11. Braak H, Tredici KD, Rüb U et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
12. Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Psychiatry 1960; 23: 283-90.
13. Goldstein DS, Pechnik S, Holmes C et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 2003; 42: 136-42.
14. Barbic F, Perego F, Canesi M et al. Early abnormalities of vascular and cardiac autonomic control in Parkinsosn's disease without orthostatic hypotension. Hypertension 2007; 49: 120-6.
15. Goldstein DS, Holmes C, Sharabi Y et al. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 2003; 60: 1327-32.
16. Oka H, Morita M, Onouchi K et al. Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease. J Neurol Sci 2007; 254: 72-7.